Because mutations in AMH and AMHR2 have been identified in patients with PMDS (3), we had the opportunity to use the structure to understand how these mutations may affect AMH signaling through AMHR2. This evidence concerns the gene AMHR2 and persistent Mullerian duct syndrome.